Polaryx Therapeutics, Inc. · NASDAQ:PLYX
Polaryx Therapeutics, Inc. shareholders
As of Sep 30, 2026, 11 institutions reported holding Polaryx Therapeutics, Inc., 4.2% of its shares. Largest: Vanguard, Geode Capital and State Street. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Polaryx Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 1.74M | 3.5% | −26,791 | Nov 13, 2026 |
| Geode Capital | 139K | 0.28% | −32,241 | Nov 6, 2026 |
| State Street | 68,004 | 0.14% | +9,900 | Nov 12, 2026 |
| BlackRock | 41,012 | 0.08% | no change | Nov 13, 2026 |
| Hrt Financial LP | 33,103 | 0.07% | −48,991 | Nov 13, 2026 |
| Northern Trust | 27,987 | 0.06% | no change | Nov 16, 2026 |
| Cerity Partners LLC | 10,427 | 0.02% | new | Nov 13, 2026 |
| Allworth Financial LP | 7,727 | 0.02% | no change | Nov 17, 2026 |
| UBS | 4,355 | <0.01% | +3,072 | Nov 10, 2026 |
| Tower Research Capital LLC (TRC) | 1,855 | <0.01% | −1,147 | Nov 16, 2026 |